JP2008513432A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513432A5
JP2008513432A5 JP2007531865A JP2007531865A JP2008513432A5 JP 2008513432 A5 JP2008513432 A5 JP 2008513432A5 JP 2007531865 A JP2007531865 A JP 2007531865A JP 2007531865 A JP2007531865 A JP 2007531865A JP 2008513432 A5 JP2008513432 A5 JP 2008513432A5
Authority
JP
Japan
Prior art keywords
alkyl
membered
independently
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007531865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513432A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/002877 external-priority patent/WO2006032999A1/en
Publication of JP2008513432A publication Critical patent/JP2008513432A/ja
Publication of JP2008513432A5 publication Critical patent/JP2008513432A5/ja
Withdrawn legal-status Critical Current

Links

JP2007531865A 2004-09-21 2005-09-09 Cns状態の治療に有用なn−メチルヒドロキシエチルアミン Withdrawn JP2008513432A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61177704P 2004-09-21 2004-09-21
PCT/IB2005/002877 WO2006032999A1 (en) 2004-09-21 2005-09-09 N-methyl hydroxyethylamine useful in treating cns conditions

Publications (2)

Publication Number Publication Date
JP2008513432A JP2008513432A (ja) 2008-05-01
JP2008513432A5 true JP2008513432A5 (cg-RX-API-DMAC10.html) 2008-10-16

Family

ID=35559297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531865A Withdrawn JP2008513432A (ja) 2004-09-21 2005-09-09 Cns状態の治療に有用なn−メチルヒドロキシエチルアミン

Country Status (7)

Country Link
US (1) US20080132552A1 (cg-RX-API-DMAC10.html)
EP (1) EP1794114A1 (cg-RX-API-DMAC10.html)
JP (1) JP2008513432A (cg-RX-API-DMAC10.html)
BR (1) BRPI0515528A (cg-RX-API-DMAC10.html)
CA (1) CA2581023A1 (cg-RX-API-DMAC10.html)
MX (1) MX2007002459A (cg-RX-API-DMAC10.html)
WO (1) WO2006032999A1 (cg-RX-API-DMAC10.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2307345A4 (en) * 2008-07-01 2012-05-02 Purdue Research Foundation NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
US8993572B2 (en) 2010-04-22 2015-03-31 Intra-Cellular Therapies, Inc. Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
CN102344402B (zh) * 2010-07-30 2015-01-07 中国人民解放军军事医学科学院毒物药物研究所 苯并氮杂环羟乙基胺类化合物、其制备方法和用途
US9428506B2 (en) 2012-04-14 2016-08-30 Intra-Cellular Therapies, Inc. Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
WO2014145192A1 (en) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Organic compounds
KR102967223B1 (ko) 2013-12-03 2026-05-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
US9745300B2 (en) 2014-04-04 2017-08-29 Intra-Cellular Therapies, Inc. Organic compounds
KR20220054908A (ko) 2014-04-04 2022-05-03 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
RU2743513C2 (ru) 2016-01-26 2021-02-19 Интра-Селлулар Терапиз, Инк. Органические соединения
IL281050B2 (en) 2016-03-25 2023-04-01 Intra Cellular Therapies Inc A controlled or delayed release pharmaceutical preparation containing a deuterated compound
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
JP7013454B2 (ja) 2016-10-12 2022-02-15 イントラ-セルラー・セラピーズ・インコーポレイテッド アモルファス固体分散体
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
EP3562484B1 (en) 2016-12-29 2021-08-25 Intra-Cellular Therapies, Inc. Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
EP3600325A4 (en) 2017-03-24 2021-01-06 Intra-Cellular Therapies, Inc. UNIQUE COMPOSITIONS AND PROCESSES
JP7224333B2 (ja) 2017-07-26 2023-02-17 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2019023062A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
AU2019240226B2 (en) 2018-03-23 2024-11-28 Intra-Cellular Therapies, Inc. Organic compounds
SMT202600133T1 (it) 2018-03-23 2026-05-12 Intra Cellular Therapies Inc Composti organici
EP3801527B1 (en) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Fused gamma-carbolines for acute treatment of anxiety or depression
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
AU2019328528B2 (en) 2018-08-31 2025-01-23 Intra-Cellular Therapies, Inc. Novel methods
WO2020047408A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410680A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
AU2002320490B2 (en) 2001-07-11 2008-10-02 Elan Pharmaceuticals, Inc. N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
GB0228410D0 (en) 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds

Similar Documents

Publication Publication Date Title
JP2008523069A5 (cg-RX-API-DMAC10.html)
NO20073667L (no) [4-(heteroaryl) piperazin-1-yl]-(2,5-substituert-fenyl)metanonderivater som glycintransportor 1(GLYT-1)- inhibitorer for behandling av neurologiske og neuropsykiatriske lidelser
JP2021523225A5 (cg-RX-API-DMAC10.html)
CY1116119T1 (el) Παραγωγα ισοξαζολο-πυριδινης
JP2010504286A5 (cg-RX-API-DMAC10.html)
JP2010256891A5 (cg-RX-API-DMAC10.html)
JPWO2022138968A5 (cg-RX-API-DMAC10.html)
CY1114932T1 (el) Αντιπαρασιτικοι παραγοντες
JPH10279578A5 (cg-RX-API-DMAC10.html)
JP2009519903A5 (cg-RX-API-DMAC10.html)
JP2013515037A5 (cg-RX-API-DMAC10.html)
JP2008518900A5 (cg-RX-API-DMAC10.html)
JP2020535124A5 (cg-RX-API-DMAC10.html)
JP2007532582A5 (cg-RX-API-DMAC10.html)
BRPI0409471A (pt) processo para a preparação de 2-cianopirrolidinas n-substituìdas
JP2007538042A5 (cg-RX-API-DMAC10.html)
JP2024512818A5 (cg-RX-API-DMAC10.html)
WO2007147770A3 (en) Substituted phenyl methanone derivatives
JP2007517826A5 (cg-RX-API-DMAC10.html)
JP2004527639A5 (cg-RX-API-DMAC10.html)
JP2009508952A5 (cg-RX-API-DMAC10.html)
JP2010123951A5 (cg-RX-API-DMAC10.html)
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
JP2010123952A5 (cg-RX-API-DMAC10.html)
JP2005517707A5 (cg-RX-API-DMAC10.html)